Safety production alarm bell ringing
Release time:
2020-08-14
Safety Production Alarm Bell Rings
6# May 16 . I had the honor to watch the safety production warning film with some employees of the pharmaceutical company in the municipal cultural center. I felt the thrilling accident scene in the film and could not calm down for a long time.
film shows several major safety accidents that have occurred recently. 2012 9 April, a manned elevator under construction in the "East Lake Scenic Area" in Wuhan City, Hubei Province suddenly lost control and fell due to overloading and unauthorized operation, resulting in the serious consequences of the death of 19 people on the spot. In 2014 , a workshop of Suzhou Kunshan Zhongrong Metal Products Co., Ltd. suffered a major aluminum dust explosion accident due to the dust system not being handled in time, dust clouds were overstocked, 75 people were killed, 185 people were injured, and the direct economic loss was 3.51 .6 billion yuan. 2015 6 , the "Oriental Star" passenger ship of Chongqing Oriental Shipping Company suddenly encountered severe convective weather on its way from Nanjing to Chongqing, and sank in Jianli waters of Hubei Province in the middle reaches of the Yangtze River, killing 442 people...
The lesson of blood and fire sounded the alarm for people again. A fresh life, instantly disappeared in the safety production accident. Safety is related to the life of each of us, and safety is the top priority of our work. Safety is the welfare of the majority of employees. Only by ensuring safe production can our hard work have a positive meaning to our own lives. I think, should do the following:
first, to establish the idea of safety first. All kinds of safety accidents, traced back to the source, are all caused by weak safety awareness and carelessness. We must be deeply aware of the importance of security and always put security in the first place. When there is a contradiction between production and safety, there must be no fluke mentality, and must not risk illegal operations. We must take precautions and prevent accidents.
Second, we must earnestly study the knowledge of safe production. Only by mastering various safety knowledge can we effectively prevent the occurrence of various accidents, better personal protective measures, improve the consciousness of safe production, and ensure stable and effective safe production of enterprises.
Third, actively participate in various safety activities. Through participating in various safety knowledge training and emergency drills and other activities, we can understand all kinds of basic knowledge of safety production, master the operation and use of safety protection, fire protection and other equipment, so as to improve the ability to deal with all kinds of accidents.
Fourth, we must earnestly implement various rules and regulations, policies and regulations. Every rule, policy, and regulation is written in blood and lessons, and cannot be ignored. If you do not abide by the rules and regulations, accidents will inevitably occur.
Therefore, every employee should improve safety production skills, eliminate fluke psychology, put an end to illegal behavior, and let safety accompany you, me and him. (Pharmaceutical Company Qiubin Pharmaceutical Factory Hong Zhiwei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page